Merck Tbk Asset Resilience Ratio
Merck Tbk asset resilience ratio. Merck Tbk (MERK) has an Asset Resilience Ratio of 6.75% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Merck Tbk liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Merck Tbk (2000–2024)
Asset resilience ratio of Merck Tbk from 2000 to 2024. This chart shows how Merck Tbk's Asset Resilience Ratio has changed over time. Read Merck Tbk total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Merck Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MERK total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp68.00 Billion | 6.75% |
| Total Liquid Assets | Rp68.00 Billion | 6.75% |
Asset Resilience Insights
- Limited Liquidity: Merck Tbk maintains only 6.75% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Merck Tbk Industry Peers by Asset Resilience Ratio
Compare Merck Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Merck Tbk Asset Resilience Ratio by Year (2000–2024)
Merck Tbk asset resilience ratio by year from 2000 to 2024. The table below shows the annual Asset Resilience Ratio data for Merck Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.93% | Rp28.00 Billion ≈ $1.64 Million |
Rp956.94 Billion ≈ $56.07 Million |
+0.91pp |
| 2023-12-31 | 2.02% | Rp19.31 Billion ≈ $1.13 Million |
Rp957.81 Billion ≈ $56.12 Million |
-5.66pp |
| 2022-12-31 | 7.67% | Rp79.61 Billion ≈ $4.67 Million |
Rp1.04 Trillion ≈ $60.80 Million |
+2.37pp |
| 2021-12-31 | 5.30% | Rp54.40 Billion ≈ $3.19 Million |
Rp1.03 Trillion ≈ $60.14 Million |
-5.07pp |
| 2020-12-31 | 10.37% | Rp96.40 Billion ≈ $5.65 Million |
Rp929.90 Billion ≈ $54.49 Million |
+2.10pp |
| 2019-12-31 | 8.27% | Rp74.50 Billion ≈ $4.37 Million |
Rp901.06 Billion ≈ $52.80 Million |
-- |
| 2017-12-31 | 0.00% | Rp0.00 ≈ $0.00 |
Rp847.01 Billion ≈ $49.63 Million |
-- |
| 2016-12-31 | 13.31% | Rp99.00 Billion ≈ $5.80 Million |
Rp743.93 Billion ≈ $43.59 Million |
+11.01pp |
| 2005-12-31 | 2.29% | Rp5.00 Billion ≈ $292.98K |
Rp218.03 Billion ≈ $12.78 Million |
-3.40pp |
| 2004-12-31 | 5.69% | Rp11.41 Billion ≈ $668.59K |
Rp200.47 Billion ≈ $11.75 Million |
-5.96pp |
| 2003-12-31 | 11.65% | Rp23.33 Billion ≈ $1.37 Million |
Rp200.33 Billion ≈ $11.74 Million |
-7.11pp |
| 2002-12-31 | 18.75% | Rp32.32 Billion ≈ $1.89 Million |
Rp172.34 Billion ≈ $10.10 Million |
+5.13pp |
| 2001-12-31 | 13.62% | Rp22.17 Billion ≈ $1.30 Million |
Rp162.72 Billion ≈ $9.53 Million |
+12.47pp |
| 2000-12-31 | 1.16% | Rp1.50 Billion ≈ $87.89K |
Rp129.68 Billion ≈ $7.60 Million |
-- |
About Merck Tbk
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an… Read more